Explore more topics
SEC Form 4 research

Wave Life Sciences, Inc. insider transactions

Inspect Wave Life Sciences, Inc.'s public SEC insider acquisitions and sales, reporting owners and source receipts.

As of 2026-10-15T08:02:39.132Z

Issuer CIK
0001631574
Reporting owners
29
Officers and directors
15
Jump to a section

What is a Form 4?

Animation: what a Form 4 is, shown with one real example. Sonic Automotive (SAH) reporting owner Paul P. Rusnak bought 13,701 shares at $59.78 on Wednesday, October 7, 2026, transaction code P, an open-market purchase (S is a sale and A is an award from the company). A timeline marks the SEC's two-business-day filing deadline, which ends Friday, October 9. The SEC accepted the Form 4 at 4:33:21 PM ET on October 9, and NexusTrade treats it as public one minute later, at 4:34:21 PM ET. A lamp for NexusTrade's InsiderTrades indicator stays off from the trade date until that moment, then counts one purchase worth 13,701 × $59.78 = $819,045.78.
In this example the shares were bought on Oct 7, 2026, and NexusTrade's InsiderTrades indicator can count the purchase starting at 4:34:21 PM ET on Oct 9, one minute after the SEC accepted the Form 4.

A Form 4 is the SEC filing a company insider, such as an officer, director or 10% owner, uses to report a trade in the company's stock, generally within two business days. The animation follows one real filing as an example: Paul P. Rusnak's purchase of Sonic Automotive (SAH) shares on October 7, 2026.

The same reading applies to every row on this page. The trade date is when the shares changed hands. The available date is when NexusTrade treats the filing as public, and a NexusTrade InsiderTrades indicator counts a purchase (code P) or sale (code S) only from that moment. Code A awards are not counted as purchases.

Read one actual disclosure before using it

Show the table · 1 row, 7 columns

Scroll sideways to compare all columns. Select a heading to sort.

2026-10-082026-10-05Kolchinsky Peter, RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Shah Rajeev M.A10,700$0Not reported

First displayed source row from Recent insider disclosures. The full bounded history and coverage notes remain below.

The displayed observation date is 2026-10-05 and its public availability date is 2026-10-08. Subtracting those calendar dates gives 3 days of disclosure lag. Historical public research can use the record from the availability date, rather than backdating knowledge to the observation date. The calendar-day difference does not assert an intraday publication time.

This row is code A: a award. An award is an acquisition but is not an open-market purchase. A purchase-following rule must not count it as code P.

Open the linked original receipts to verify the row, then inspect a second record before drawing a pattern. This public filing observation supplies source evidence, not a completed copy-trading return.

SEC accession 0001231919-26-001433 ↗SEC accession 0001231919-26-001433 ↗SEC accession 0001193125-26-417237 ↗

Recent insider disclosures

Inspect all 20 displayed rows: Recent insider disclosures

This table includes purchases, sales and awards in the public filing record. Awards and open-market purchases are distinct transaction codes. For historical research, use the public availability date to determine when the transaction was knowable.

Read code P as a purchase, S as a sale and A as an award. An award is an acquisition, but it is not an open-market purchase. Open the filing receipt to check the transaction details.

Scroll sideways to compare all columns. Select a heading to sort.

2026-10-082026-10-05Kolchinsky Peter, RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Shah Rajeev M.A10,700$0Not reported
2026-10-082026-10-05Kolchinsky Peter, RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Shah Rajeev M.A64,000$0Not reported
2026-10-082026-10-05Verdine Gregory L.A10,700$0Not reported
2026-10-082026-10-05Verdine Gregory L.A64,000$0Not reported
2026-10-082026-10-05Tan Aik NaA10,700$0Not reported
2026-10-082026-10-05Tan Aik NaA64,000$0Not reported
2026-10-082026-10-05TAKANASHI KENA10,700$0Not reported
2026-10-082026-10-05TAKANASHI KENA64,000$0Not reported
2026-10-082026-10-05CORRIGAN MARKA10,700$0Not reported
2026-10-082026-10-05CORRIGAN MARKA64,000$0Not reported
2026-10-082026-10-05Rawcliffe AdrianA10,700$0Not reported
2026-10-082026-10-05Rawcliffe AdrianA64,000$0Not reported
2026-10-082026-10-05Wagner Heidi LA10,700$0Not reported
2026-10-082026-10-05Wagner Heidi LA64,000$0Not reported
2026-10-082026-10-05HENRY CHRISTIAN OA10,700$0Not reported
2026-10-082026-10-05HENRY CHRISTIAN OA64,000$0Not reported
2026-08-142026-08-11Wagner Heidi LS7,000$6.01Not reported
2026-08-142026-08-12Rawcliffe AdrianS12,700$5.29Not reported
2026-08-142026-08-11TAKANASHI KENS3,864$6.01Not reported
2026-08-142026-08-11Tan Aik NaS432$6.01Not reported

Most recent 90-day source activity, up to 50 rows. No rows means no matching recent records, not no historical activity.

Officers and directors in the directory

Inspect all 19 displayed rows: Officers and directors in the directory

Scroll sideways to compare all columns. Select a heading to sort.

Gaiero David G00017997841
Francis Chris000165770934
BOLNO PAUL000165771030
CORRIGAN MARK000125066199
HENRY CHRISTIAN O0001263805326
Kolchinsky Peter00013848591,083
Moran Kyle000165776514
Panzara Michael A.000167903911
RA Capital Healthcare Fund LP00013150821,055
RA CAPITAL MANAGEMENT, L.P.00013468241,081
Rawcliffe Adrian000155585134
Regnante Keith000168206810
Shah Rajeev M.0001619841388
TAKANASHI KEN00016577685
Tan Aik Na000182128511
Tanaka Masaharu00016577714
Vargeese Chandra000165767512
Verdine Gregory L.000157231511
Wagner Heidi L000165502929
Gaiero David G ↗Francis Chris ↗BOLNO PAUL ↗CORRIGAN MARK ↗HENRY CHRISTIAN O ↗Kolchinsky Peter ↗Moran Kyle ↗Panzara Michael A. ↗RA Capital Healthcare Fund LP ↗RA CAPITAL MANAGEMENT, L.P. ↗Rawcliffe Adrian ↗Regnante Keith ↗Shah Rajeev M. ↗TAKANASHI KEN ↗Tan Aik Na ↗Tanaka Masaharu ↗Vargeese Chandra ↗Verdine Gregory L. ↗Wagner Heidi L ↗

Which transactions qualify for the company tracker

The company strategy uses verified officers and directors with qualifying acquisitions at this issuer. Other reporting owners may appear in source records without becoming strategy signals.

Strategy eligibility is held while filing coverage is unresolved.

Historical follower simulations are separate from these source transactions. They do not establish live trading results.